Nigeria, Feb. 28 -- The Johnson & Johnson vaccine on Saturday received emergency use authorisation from the U.S. Food and Drug Administration making it the third approved vaccine for the prevention of COVID-19.

The vaccine will be administered in the U.S to individuals 18 years of age and older.

"The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States," said Acting FDA Commissioner Janet Woodcock, M.D., according to a statement on the agency's website.

"The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccine...